Logo image of LNZA

LANZATECH GLOBAL INC (LNZA) Stock Fundamental Analysis

NASDAQ:LNZA - Nasdaq - US51655R1014 - Common Stock - Currency: USD

0.1747  -0.03 (-12.65%)

After market: 0.1807 +0.01 (+3.43%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LNZA. LNZA was compared to 83 industry peers in the Commercial Services & Supplies industry. The financial health of LNZA is average, but there are quite some concerns on its profitability. LNZA is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year LNZA has reported negative net income.
LNZA had a negative operating cash flow in the past year.
LNZA had negative earnings in 4 of the past 5 years.
In the past 5 years LNZA always reported negative operating cash flow.
LNZA Yearly Net Income VS EBIT VS OCF VS FCFLNZA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -59.85%, LNZA is doing worse than 91.57% of the companies in the same industry.
Looking at the Return On Equity, with a value of -951.21%, LNZA is doing worse than 89.16% of the companies in the same industry.
Industry RankSector Rank
ROA -59.85%
ROE -951.21%
ROIC N/A
ROA(3y)-19.35%
ROA(5y)N/A
ROE(3y)-40.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LNZA Yearly ROA, ROE, ROICLNZA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

LNZA has a Gross Margin of 44.17%. This is in the better half of the industry: LNZA outperforms 77.11% of its industry peers.
LNZA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 44.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LNZA Yearly Profit, Operating, Gross MarginsLNZA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100 -150 -200

More info and screens

4

2. Health

2.1 Basic Checks

LNZA does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for LNZA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
LNZA Yearly Shares OutstandingLNZA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 50M 100M 150M
LNZA Yearly Total Debt VS Total AssetsLNZA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of -6.77, we must say that LNZA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of LNZA (-6.77) is worse than 90.36% of its industry peers.
LNZA has a Debt/Equity ratio of 4.53. This is a high value indicating a heavy dependency on external financing.
LNZA has a worse Debt to Equity ratio (4.53) than 85.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.53
Debt/FCF N/A
Altman-Z -6.77
ROIC/WACCN/A
WACC8.98%
LNZA Yearly LT Debt VS Equity VS FCFLNZA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 50M -50M 100M -100M

2.3 Liquidity

LNZA has a Current Ratio of 2.91. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of LNZA (2.91) is better than 84.34% of its industry peers.
LNZA has a Quick Ratio of 2.91. This indicates that LNZA is financially healthy and has no problem in meeting its short term obligations.
LNZA has a better Quick ratio (2.91) than 89.16% of its industry peers.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 2.91
LNZA Yearly Current Assets VS Current LiabilitesLNZA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 50M 100M 150M

More info and screens

4

3. Growth

3.1 Past

LNZA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.02%, which is quite impressive.
The Revenue has grown by 37.57% in the past year. This is a very strong growth!
EPS 1Y (TTM)33.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.46%
Revenue 1Y (TTM)37.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.28%

3.2 Future

Based on estimates for the next years, LNZA will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.60% on average per year.
Based on estimates for the next years, LNZA will show a quite strong growth in Revenue. The Revenue will grow by 18.61% on average per year.
EPS Next Y13.18%
EPS Next 2Y21.27%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue Next Year-22.43%
Revenue Next 2Y17.26%
Revenue Next 3Y18.61%
Revenue Next 5YN/A

3.3 Evolution

LNZA Yearly Revenue VS EstimatesLNZA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 20M 40M 60M 80M 100M
LNZA Yearly EPS VS EstimatesLNZA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -0.2 -0.4 -0.6

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

LNZA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LNZA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LNZA Price Earnings VS Forward Price EarningsLNZA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNZA Per share dataLNZA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

LNZA's earnings are expected to grow with 16.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.27%
EPS Next 3Y16.6%

More info and screens

0

5. Dividend

5.1 Amount

LNZA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

LANZATECH GLOBAL INC

NASDAQ:LNZA (4/17/2025, 8:00:00 PM)

After market: 0.1807 +0.01 (+3.43%)

0.1747

-0.03 (-12.65%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)04-15 2025-04-15/amc
Earnings (Next)05-07 2025-05-07/bmo
Inst Owners63.64%
Inst Owner Change0%
Ins Owners2.12%
Ins Owner Change0%
Market Cap34.57M
Analysts78
Price Target2.68 (1434.06%)
Short Float %6.6%
Short Ratio6.93
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.61%
Min EPS beat(2)-49.87%
Max EPS beat(2)-19.35%
EPS beat(4)0
Avg EPS beat(4)-20.6%
Min EPS beat(4)-49.87%
Max EPS beat(4)-1.15%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-12.47%
Min Revenue beat(2)-45.67%
Max Revenue beat(2)20.73%
Revenue beat(4)1
Avg Revenue beat(4)-20.19%
Min Revenue beat(4)-45.67%
Max Revenue beat(4)20.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.5%
PT rev (3m)-30%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.73%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.77%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.6
P/FCF N/A
P/OCF N/A
P/B 2.54
P/tB 2.54
EV/EBITDA N/A
EPS(TTM)-0.55
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.46
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS0.29
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -59.85%
ROE -951.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 44.17%
FCFM N/A
ROA(3y)-19.35%
ROA(5y)N/A
ROE(3y)-40.55%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 4.53
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 86.27%
Cap/Sales 8.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.91
Quick Ratio 2.91
Altman-Z -6.77
F-Score3
WACC8.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-38.46%
EPS Next Y13.18%
EPS Next 2Y21.27%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue 1Y (TTM)37.57%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-49.28%
Revenue Next Year-22.43%
Revenue Next 2Y17.26%
Revenue Next 3Y18.61%
Revenue Next 5YN/A
EBIT growth 1Y-11.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year13.21%
EBIT Next 3Y13.17%
EBIT Next 5YN/A
FCF growth 1Y-11752.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-11098.7%
OCF growth 3YN/A
OCF growth 5YN/A